COVID-19

News

UK initiative aims to cut COVID-19 drug development to a few...

A new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks.

News

AZ maintains 2020 guidance as Q1 sales grow despite pandemic

The ongoing pandemic will not affect AstraZeneca’s performance in 2020, the company has said after its first quarter results beat analysts’ expectations.

Views & Analysis

Maintaining patient access to care during COVID-19

COVID-19 casts a spotlight on the need for healthcare providers to interact with people virtually, address the affordability crisis compounded by the pandemic, and alleviate the challenges

News

COVID-19 to hurt 2020 revenues, says Merck & Co

Merck & Co has lowered its full-year revenue and earnings estimates because of the impact of COVID-19 on its business, which is focused on products administered in hospitals. <

News

Jury still out on IL-6 drugs in COVID-19 following prelimina...

There is a growing body of evidence that already-approved IL-6 could be used as treatments for COVID-19 following newly published clinical trial data – but the jury is out on whether they c

News

Neurocrine delays US Parkinson's drug launch amid COVID disr...

The FDA has approved Ongentys, an oral Parkinson’s Disease drug from US biotech Neurocrine Biosciences, which can be added to prolong the effects of standard therapy and help prevent “off”

UK initiative aims to cut COVID-19 drug development to a few...

AZ maintains 2020 guidance as Q1 sales grow despite pandemic

Maintaining patient access to care during COVID-19

COVID-19 to hurt 2020 revenues, says Merck & Co

Jury still out on IL-6 drugs in COVID-19 following prelimina...

Neurocrine delays US Parkinson's drug launch amid COVID disr...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks